期刊文献+

碘海醇脂质体的制备及其质量评价 被引量:2

Preparation and Quality Evaluation of Iohexol Liposomes
下载PDF
导出
摘要 采用逆相蒸发法制备碘海醇脂质体。对脂质体的形态、包封率、粒径分布、体外释放及体内造影情况等性质进行研究。透射电镜下观察脂质体为粒径均匀的球状或近球状小囊泡。HPLC法测定碘海醇脂质体包封率为82.35%±1.82%。碘海醇脂质体平均粒径207.7nm,分散指数0.355,Zeta电位-1.83mV。体外释放度试验表明碘海醇脂质体中药物的释放明显比碘海醇单纯药物缓慢,24h才达到98.57%。体内试验结果表明脂质体包裹的造影剂比普通造影剂CT峰值推后,信号增强,作用时间延长。碘海醇脂质体包封率较高、重现性良好。将碘海醇包裹于脂质体后减少给药剂量、延长作用时间,并可能减小对血管和中枢神经的毒性。 The liposomes were prepared by reverse-phase evaporation technique. The morphology of the liposomes, the entrapment efficiency and the particle size distribution were evaluated. The CT signals of Iohexol liposomes in rabbits were compared with those of Iohexol injection in rabbits. The entrapment efficiency of Iohexol liposomes was 82.35%± 1.82%. The liposmes were spherical or ellipsoidal shape in shape. The mean diameter of the Iohexol liposomes was 207.7 nm. The polydispersity index was 0. 355. The Zeta potential was - 1.83 inV. The drug was highly entrapped into the liposomes with good reproduction and stability. The in vitro release of Iohexol liposomes was significantly slower than that of Iohexol,and was 98.57% at 24 h. Iohexol liposomes may reduce the dosage, prolong the effective time of the developing agent, and could reduce the side effects of Iohexol on the blood vessels and cerebral nerves.
出处 《生物医学工程学杂志》 EI CAS CSCD 北大核心 2007年第4期918-922,共5页 Journal of Biomedical Engineering
关键词 碘海醇 脂质体 质量评价 Iohexol Liposomes Quality evaluation
  • 相关文献

参考文献7

二级参考文献19

  • 1薛玉英,翁帼英.阿糖腺苷脂质体含量及包封率测定[J].中国医药工业杂志,1993,24(4):160-164. 被引量:3
  • 2钟玉莲.紫外分光光度法测定欧乃派克注射液的含量[J].西北药学杂志,1994,9(4):149-150. 被引量:3
  • 3罗世能,谢敏浩,奚月芬,张满达,孟虹,刘娅灵,黄荷云,邹霈.非离子型X-CT造影剂碘海醇的合成[J].中国医药工业杂志,1995,26(10):433-435. 被引量:21
  • 4[1] Leenders ACAP, Marie SD. The use of lipid formulation of amphotericin B for systemic fungal infectious[J].Leukemia, 1996, 10:1570.
  • 5[2] Jill PA, Richard TP. Development, characterization, efficacy and mode of action of ambisome,a unilamellar liposomal formulation of amphotericin B[J].Journal of liposome Research,1993,3(3):429.
  • 6[3] Marie SD. Liposomal and lipid-based formulations of amphotericin B[J].Leukemia,1996,10(Suppl.2):S93.
  • 7[1]Shibata S, Kumai K, Takahashi T, Murayama Y, Ishibiki K, Kitajima M. Targeting cancer chemotherapy using temperature-sensitive liposomes containing adriamycin conjugated with monoclonal antibodies [J]. Gan To Kagaku Ryoho, 1992;19(10 Suppl):1671-1674.
  • 8[2]Lopez-Amaya C, Marangoni AG. Comparison of dynamic and integrated light-scattering techniques in the study of the interaction of Candida rugosa lipase with DPPC liposomes [J]. Biophys Chem,1999;80(2):69-83.
  • 9[3]Kruk I, Michalska T, Kladny J, Kubera-Nowakowska L. Luminescence investigations of redox cycling of adriamycin [J]. Chemosphere, 2001;44(1):83-90.
  • 10[4]Zagotto G, Gatto B, Moro S, Sissi C, Palumbo M. Anthracyclines: Recent developments in their separation and quantitation [J]. J Chromatogr B Biomed Sci Appl, 2001; 25;764(1-2):161-171.

共引文献93

同被引文献23

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部